Kolexia
Malard Florent Hématologie
Malard Florent
Hématologie
Hôpital Saint-Antoine
Paris, France
404 Activités
1 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie du greffon contre l'hôte Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Myélome multiple Tumeurs hématologiques Maladie aigüe Syndromes myélodysplasiques Sclérodermie systémique

Collaborateurs

Voir plus
Mohty Mohamad
Mohty Mohamad
Hôpital Saint-Antoine, Paris, France
Brissot Eolia
Brissot Eolia
Hôpital Saint-Antoine, Paris, France
Dulery Remy
Dulery Remy
Hôpital Saint-Antoine, Paris, France
Chevallier Patrice
Chevallier Patrice
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
B3TSI
38 collaboration(s)
Dernière en 2023
Sanofi
11 collaboration(s)
Dernière en 2022
Therakos
9 collaboration(s)
Dernière en 2022
Novartis
6 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
Blood cancer journal   19 février 2024
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation.
Bone marrow transplantation   13 février 2024
HLA Mismatching and Transplant Outcome in the Ptcy Era: A Comprehensive Study By the EBMT Cellular Therapy and Immunobiology Working Party
Abstracts from the 2024 Tandem Meetings of ASTCT and CIBMTR, February 21-24, 2024, San Antonio, Texas, USA   01 février 2024
Melanoma and microbiota: Current understanding and future directions.
Cancer cell   28 décembre 2023
Les selles de la vie : épisode • 2/4 du podcast Microbiote : tous en ...
Radio France   28 novembre 2023
Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial): A Multi-center Randomized, Double Blinded Phase IIb Trial Evaluating Oral Pooled Fecal Microbiotherapy MaaT033 to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)
Essai Clinique (MaaT Pharma)   06 novembre 2023
Potential future direction of measurable residual disease evaluation in multiple myeloma.
Blood   03 novembre 2023
Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease : Results from Early Access Program in Europe
65th ASH Annual Meeting Abstracts   02 novembre 2023
HLA Class I Mismatches Reduce Survival after HCT in the Ptcy Era: A Study By the EBMT Cellular Therapy and Immunobiology Working Party
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Multicentre, Randomized, Double-Blinded, Phase 2b Study Evaluating the Efficacy and Safety of MaaT033, an Oral, Pooled Microbiome Ecosystem Therapy in Patients Undergoing Allogenic Hematopoietic Cell Transplantation to Improve Overall Survival: The Phoebus Trial
65th ASH Annual Meeting Abstracts   02 novembre 2023